封面
市場調查報告書
商品編碼
1589003

智慧胰島素筆和幫浦的全球市場

Smart Insulin Pens and Pumps

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球智慧胰島素筆和幫浦市場將達到 92 億美元

智慧胰島素筆和幫浦的全球市場預計 2023 年為 52 億美元,預計到 2030 年將達到 92 億美元,2023-2030 年分析期間複合年成長率為 8.6%。智慧胰島素幫浦是本報告分析的細分市場之一,預計複合年成長率為 8.1%,到分析期結束時將達到 79 億美元。分析期間,智慧胰島素筆產業的複合年成長率預計為 12.7%。

美國市場預計14億美元,中國預計複合年成長率8.2%

預計 2023 年美國智慧胰島素筆和幫浦市場規模將達 14 億美元。中國作為世界第二大經濟體,預計到 2030 年市場規模將達到 14 億美元,2023-2030 年分析期間複合年成長率為 8.2%。其他值得注意的區域市場包括日本和加拿大,在分析期間預計複合年成長率分別為 8.1% 和 7.1%。在歐洲,德國的複合年成長率預計約為 7.0%。

全球智慧胰島素筆和幫浦市場—主要趨勢和促進因素總結

智慧胰島素筆和幫浦如何增強糖尿病管理?

智慧胰島素筆和幫浦是先進的醫療設備,旨在透過提供準確、即時的資料和個人化的胰島素劑量來改善糖尿病管理。智慧筆提供測量量的胰島素,智慧幫浦根據使用者的血糖濃度提供連續的皮下胰島素輸注。這些設備提供藍牙連接、劑量追蹤和行動應用程式整合等功能,使用戶能夠準確監控和調整胰島素的使用情況。智慧胰島素筆和幫浦透過支援個人化治療和降低併發症風險,正在改變第 1 型和第 2 型糖尿病患者的糖尿病照護。

智慧胰島素筆和幫浦市場的關鍵細分市場有哪些?

主要產品類型包括智慧胰島素筆、智慧胰島素幫浦和連網型胰島素帽,其中智慧胰島素幫浦因其連續血糖監測(CGM)支援和自動化胰島素給藥能力而佔據最大的市場佔有率。主要應用是第1型糖尿病和第2型糖尿病,其中第1型糖尿病佔重要部分,因為第1型糖尿病患者需要持續的胰島素管理。最終用戶包括醫院、診所和居家醫療,由於糖尿病患者擴大採用自我管理工具,居家醫療引領市場。

智慧胰島素設備如何融入糖尿病照護?

智慧胰島素筆具有劑量記憶、劑量建議和錯過劑量警報等功能,可幫助使用者有效管理用餐時間並修正胰島素。智慧型幫浦通常與連續血糖監測 (CGM) 系統整合,根據血糖讀數自動調整胰島素輸送,以支援穩定的血糖值。在醫院和診所,這些設備用於改善胰島素治療效果、減少錯誤,並向醫療保健專業人員提供即時資料以進行病患監測。此外,家庭護理患者可以使用與智慧筆和幫浦配合使用的行動應用程式來追蹤胰島素使用情況、查看血糖趨勢並接受個人化治療調整,以支持更好的自我護理和依從性。

推動智慧胰島素筆和幫浦市場成長的因素有哪些?

智慧胰島素筆和幫浦市場的成長受到多種因素的推動,包括糖尿病盛行率的增加以及對更有效的胰島素管理解決方案的需求不斷成長。連接性、劑量準確性和 CGM 整合等設備技術的進步正在提高使用者便利性和治療效果。人們對糖尿病治療中的個人化醫療和自我管理的日益關注正在加速智慧胰島素設備的採用。隨著患者尋求先進的解決方案來提高生活品質,政府促進數位健康和​​慢性病管理的措施進一步推動了需求。此外,醫療保健提供者對減少再入院和改善患者治療效果的關注也促進了智慧胰島素筆和幫浦的普及。

受訪企業範例(33家知名企業)

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP22791

Global Smart Insulin Pens and Pumps Market to Reach US$9.2 Billion by 2030

The global market for Smart Insulin Pens and Pumps estimated at US$5.2 Billion in the year 2023, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Smart Insulin Pens segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 8.2% CAGR

The Smart Insulin Pens and Pumps market in the U.S. is estimated at US$1.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Smart Insulin Pens and Pumps Market - Key Trends and Drivers Summarized

How Are Smart Insulin Pens and Pumps Enhancing Diabetes Management?

Smart insulin pens and pumps are advanced medical devices designed to improve diabetes management by providing accurate, real-time data and personalized insulin delivery. Smart pens deliver insulin in measured doses, while smart pumps provide continuous subcutaneous insulin infusion based on the user's glucose levels. These devices offer features like Bluetooth connectivity, dose tracking, and integration with mobile apps, enabling users to monitor and adjust insulin usage with precision. By supporting personalized therapy and reducing the risk of complications, smart insulin pens and pumps are transforming diabetes care for both Type 1 and Type 2 diabetics.

What Are the Key Segments in the Smart Insulin Pens and Pumps Market?

Key product types include smart insulin pens, smart insulin pumps, and connected insulin caps, with smart insulin pumps holding the largest market share due to their continuous glucose monitoring (CGM) compatibility and ability to automate insulin delivery. Major applications cover Type 1 and Type 2 diabetes, with Type 1 diabetes representing a significant segment as these patients require consistent insulin management. End-users include hospitals, clinics, and home care, with home care leading the market due to the increasing adoption of self-management tools by diabetic patients.

How Are Smart Insulin Devices Integrated Across Diabetes Care?

Smart insulin pens are equipped with dose memory, dose recommendations, and missed dose alerts, helping users manage mealtime and correction insulin effectively. Smart pumps, often integrated with continuous glucose monitoring (CGM) systems, automatically adjust insulin delivery based on glucose readings, supporting stable blood sugar levels. In hospitals and clinics, these devices are used to improve insulin therapy outcomes, reduce errors, and provide real-time data to healthcare professionals for patient monitoring. Additionally, home care patients use mobile apps linked to smart pens and pumps to track insulin usage, review glucose trends, and receive personalized therapy adjustments, supporting better self-care and adherence.

What Factors Are Driving the Growth in the Smart Insulin Pens and Pumps Market?

The growth in the Smart Insulin Pens and Pumps market is driven by several factors, including increasing diabetes prevalence, which has heightened the need for more effective insulin management solutions. Advancements in device technology, such as improved connectivity, dose accuracy, and CGM integration, have enhanced user convenience and therapy outcomes. The rising focus on personalized medicine and self-management in diabetes care has accelerated the adoption of smart insulin devices. Government initiatives promoting digital health and chronic disease management have further fueled demand, as patients seek advanced solutions to improve quality of life. Additionally, healthcare providers’ focus on reducing hospital readmissions and improving patient outcomes has contributed to the widespread adoption of smart insulin pens and pumps.

Select Competitors (Total 33 Featured) -

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Smart Insulin Pens and Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Spurs Demand for Smart Insulin Pens and Pumps
    • Technological Advancements in Real-Time Glucose Monitoring and Automated Insulin Delivery Drive Adoption
    • Growing Focus on Personalized Diabetes Management Expands Addressable Market for Smart Insulin Devices
    • Expansion of Smart Insulin Solutions in Home Healthcare and Remote Patient Monitoring Fuels Market Growth
    • Increasing Demand for Accurate Dosing, Safety Alerts, and Predictive Analytics Drives Adoption
    • Integration with Mobile Apps, AI-Powered Coaching, and Data Analytics Strengthens Business Case
    • Rising Focus on Patient Adherence, Dosage Tracking, and Data-Driven Insights Accelerates Demand
    • Technological Innovations in Needle-Free Insulin Delivery and Wearable Infusion Pumps Propel Market Growth
    • Growing Use of Smart Insulin Devices in Pediatrics, Geriatrics, and Special Populations Drives Adoption
    • Focus on Achieving Seamless Integration with Telehealth Platforms Expands Addressable Market
    • Technological Advancements in Long-Lasting Battery, Compact Design, and Bluetooth Connectivity Propel Growth
    • Rising Demand for Cost-Effective, Reusable, and Disposable Smart Insulin Devices Generates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Smart Insulin Pens and Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 16: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • JAPAN
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CHINA
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 28: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • EUROPE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • FRANCE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 36: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 38: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • GERMANY
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • UNITED KINGDOM
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 48: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 50: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030

IV. COMPETITION